Ming‐Chao Tsai - Concepedia

Author

Ming‐Chao Tsai

Also Known As

An-Che Liu, Chih-Chi Wang, M. Tsai, M.-C. Tsai, M.C. Tsai, Mei-Lang Kung, Ming-Chao Tsai, Ming-Chao Tsai (544594), Ming-Chao Tsai(Former Corresponding Author), Ming‐Chao Tsai

132

Publications

Citations

H-Index

Concepts

All Affiliations

Chang Gung University Kaohsiung Chang Gung Memorial Hospital Chiayi Chang Gung Memorial Hospital National Sun Yat-sen University Linkou Chang Gung Memorial Hospital

About

Ming‐Chao Tsai is an author at Chang Gung University specializing in hepatology, medicine, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	321
2	Health Sciences	5	5	99
3	Public Health	2	2	22
4	Epidemiology	2	2	22
5	Cell Biology	1	1	25

Ming‐Chao Tsai

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection David Y. Zhang, Nicolas Goossens, Ming‐Chao Tsai, Gut	2015	127
Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan Ming‐Chao Tsai, Yu-Yin Liu, Chih‐Che Lin, Nutrients	2020	89
Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community Jing‐Houng Wang, Kuo‐Chin Chang, Kwong‐Ming Kee, The American Journal of Gastroenterology	2013	75
Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease Yu-Chieh Tsai, Wei‐Chen Tai, Chih‐Ming Liang, Journal of Microbiology Immunology and Infection	2024	70
APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level Yi‐Hao Yen, Fang-Ying Kuo, Kwong-Ming Kee, PLoS ONE	2018	63
Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience Ming‐Chao Tsai, Chia‐Hsiang Chen, Po‐Lin Tseng, Clinical Microbiology and Infection Renal SafetyUrologyReal World ExperienceHepatologyTenofovir Treatment	2015	61
A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection Kuo‐Chin Chang, Po‐Lin Tseng, Yi‐Ying Wu, Clinical Gastroenterology and Hepatology	2014	55
Favorable α‐fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation Ming‐Chao Tsai, Jing‐Houng Wang, Chao‐Hung Hung, Journal of Gastroenterology and Hepatology	2010	45
Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease Yi‐Hao Yen, Kuo‐Chin Chang, Ming‐Chao Tsai, Journal of the Formosan Medical Association	2017	39
The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy Yuan‐Hung Kuo, Sheng‐Nan Lu, Chien‐Hung Chen, PLoS ONE Hepatitis BLiver StiffnessCirrhosisAutoimmune Liver DiseaseHepatic Disorders	2014	35

Page 1